See all specials

Special

InsideView

InsideViews offer a window into the practices and priorities of research-based organizations. Short, accessible yet informative Q&A articles — created in collaboration with Nature’s writers — reveal the people whose products, services or institutional visions are influencing science, technology and innovation today.

Image credit: Eugene Sergeev/Shutterstock

2018

  • Transnetyx

    Darrell E. Hoskins, associate vice president, Comparative Medicine, Transnetyx, explains what can go wrong with mouse models and how these errors can be prevented.

    Lab Animal (01 October 2018)

  • University of Plymouth Peninsula Dental School

    Timothy O'Brien, Clinical Associate Professor in Restorative Dentistry and Programme Lead in Periodontology at Peninsula Dental School at the University of Plymouth, discusses the courses that they offer and what makes Plymouth different from other dental schools

    British Dental Journal (28 September 2018)

  • Biogen

    Anirvan Ghosh, head of Research and Early Development at Biogen, talks about what it's like working at the world’s largest biotechnology company focused on neuroscience.

    Nature (27 September 2018)

  • Thermo Fisher Scientific

    Christoph Hergersberg, vice president of R&D for Thermo Fisher Scientific’s Protein and Cell Analysis and Antibody and Immunoassay businesses, explains how the Invitrogen iBright Imaging Systems can dramatically simplify and improve the protein visualization process.

    Nature (06 September 2018)

  • Horizon Discovery

    Hannah Child, product manager at Horizon Discovery, discusses reference standards and why they are important. 

    Nature (06 September 2018)

  • Collaborative Drug Discovery

    Barry Bunin, chief executive officer of Collaborative Drug Discovery, explains how the ability to selectively share data can spur partnerships.

    Nature (06 September 2018)

  • Moderna

    Tal Zaks, MD, Chief Medical Officer of Moderna, explains how the company is using messenger RNA (mRNA) to develop a new class of medicines, from therapeutics to vaccines. 

    Nature (30 August 2018)

  • American University of Sharjah

    Björn Kjerkve, Chancellor, American University of Sharjah, United Arab Emirates, discusses how the university is changing and how the changes will attract PhD candidates.

    Nature (02 August 2018)

  • Evotec

    Craig Johnstone, Global Head, Integrated Drug Discovery at Evotec, discusses the launch of INDiGO.

    Nature Reviews Drugs Discovery (12 July 2018)

  • Janssen Immunology

    Shawn Rose at Janssen Research & Development, LLC, describes the company’s focus in continuing its innovation path for lupus treatment.

    Nature Immunology (01 July 2018)

  • Monash University

    Professor Rebekah Brown director of the Monash Sustainable Development Institute outlines how the university is tackling global challenges embodied by the United Nations' Sustainable Development Goals and implementing solutions to real-world problems through partnerships. 

    Nature Index 2018 Earth and Environmental Sciences (28 June 2018)

  • Horizon Discovery

    Dr David Sorrell, HTS platform leader at Horizon Discovery Ltd, discusses their CombinatoRx screening platform and custom drug screening service. 

    Nature (14 June 2018)

  • Evotec

    Werner Lanthaler, CEO of Evotec, discusses their BRIDGE initiative and Evotec's plans for more in the coming months. 

    Nature Reviews Drugs Discovery (11 June 2018)

  • USP

    Jaap Venema, Ph.D., Chief Science Officer for USP, explains how his organization stays at the forefront in developing quality standards for the rapidly evolving field of pharmaceutical science.

    Scientific American (01 June 2018)

  • Horizon Discovery

    Dr. Daniella Steel, Senior product manager at Horizon Discovery Ltd, discusses how Horizon has created a library of ready-made isogenic human cell line pairs edited using CRISPR-Cas9 technology, and what makes the library different. 

    Nature (17 May 2018)

  • Monash University

    Elizabeth Croft, Dean of Engineering at Monash University in Melbourne, Australia, discusses the large-scale collaborative research projects that she has led looking into robots working alongside people.  

    Spotlight on Robotics (10 May 2018)

  • Victorian Government

    Andrew Cuthbertson, Chief Scientific Officer & Global R&D Director of CSL Limited, outlines why CSL, a world-leading biotech firm and Australia’s sixth largest company, is based in Melbourne.

    Nature (10 May 2018)

  • Queensland University of Technology (QUT)

    Peter Corke, Professor of robotics vision at QUT, explains how robots are set to help retailers, farmers, and other industry players save time and money. 

    Spotlight on Robotics (10 May 2018)

  • Horizon Discovery

    Dr. Benedict Cross, R&D Manager, Functional Genomic Screening at Horizon Discovery Ltd discusses how they have optimized more than 50 cell lines for CRISPR screening and how Horizon supports their customers.

    Nature (12 April 2018)

  • Ipsen

    Alexandre Lebeaut, Executive Vice President R&D and Chief Scientific Officer at Ipsen, discusses their ambitious mission and how Ipsen is putting patients at the core of its strategy.

    Nature (12 April 2018)

  • Horizon Discovery

    Dr Jamie Freeman, product manager at Horizon Discovery, discusses how Horizon Discovery engineers cell lines to enable deeper understanding of basic biology of disease or build better disease models.

    Nature (22 March 2018)

  • Gilson

    Nazafarin Lahoutifard, Director of Portfolio Management for the HPLC Business at Gilson, explains how recent advances in the pumps that drive chromatographic analysis are allowing unprecedented purification and consistency.

    Nature (15 February 2018)

  • Lilly Research Laboratories

    Dan Skovronsky discusses his goals as president of Lilly Research Laboratories, the research and development arm of the 141-year-old pharmaceutical company.

    Scientific American (01 February 2018)

2017

  • Hitachi

    Masaya Watanabe, CEO of Healthcare Business Unit, Hitachi Ltd., explains how the company is expanding its capabilities by integrating artificial intelligence and other emerging technologies.

    Nature (21 December 2017)

  • Nitta Gelatin Inc

    Yosuke Hiraoka, principal research scientist at Nitta Gelatin Inc, Japan, discusses what sets the company apart from other collagen and gelatin makers and how they have evolved to meet changing demands.  

    Nature (21 December 2017)

  • Brand Chile

    Myriam Gómez, executive director of Brand Chile, discusses what makes Chile an exceptional natural lab that could hold answers to some of the most pressing scientific questions.

    Spotlight on Chile (14 December 2017)

  • Pontificia Universidad Católica de Chile

    Ignacio Sánchez, president at Pontificia Universidad Católica de Chile (PUC) explains why the university is both a Latin American gateway for collaboration and a player in several international collaborations. 

    Spotlight on Chile (14 December 2017)

  • Universidad Andrés Bello

    Ariel Orellana, vice rector of research at Universidad Andrés Bello, describes how the university has matured and why Andrés Bello is a good place to do research. 

    Spotlight on Chile (14 December 2017)

  • Universidad de Chile

    Ennio Vivaldi, rector of Universidad de Chile, discusses how the university is fostering collaboration with South American universities to showcase the knowledge generated there.

    Spotlight on Chile (14 December 2017)

  • RMIT University

    Calum Drummond, Deputy Vice-Chancellor at RMIT University discusses what research and innovation means to the university. Eight RMIT directors also discuss how they are using the university's expertise to address real-world challenges. 

    Nature Index Science Inc. 2017 (07 December 2017)

  • Ambry Genetics

    Aaron Elliott, CEO of Ambry, which is becoming an independent subsidiary of Konica-Minolta, talks about how the merger will help with the search for new drugs. 

    Nature (23 November 2017)

  • MaxCyte

    Madhusudan Peshwa, chief scientific officer at MaxCyte, describes the technology and where the company is headed. 

    Nature (09 November 2017)

  • Tencent

    Edward Cheng, Corporate Vice President of Tencent, discusses his expectations for the WE summit and Tencent’s ambition to address global challenges with technology. Find out more at: http://we.tencent.com

    Nature (09 November 2017)

  • Tohoku University

    Tetsuo Endoh, director of the Center for Innovative Integrated Electronic Systems (CIES) and professor at the Graduate School of Engineering, Tohoku University, discusses why collaborations are so important between academia, industry and government. 

    Nature (02 November 2017)

  • Bettencourt Schueller Foundation

    Déborah Bourc’his, Group Leader at the Institut Curie, PSL Research University, talks about winning the Liliane Bettencourt Prize for Life Sciences for her work on epigenetics. 

    Nature (02 November 2017)

  • Personalis

    John West, CEO of Personalis, Inc., discusses the development of the ACE ImmunoID Platform, and how it helps inform clinical and translational research through robust, comprehensive molecular data.

    Nature (26 October 2017)

  • ZEISS

    Dr. Thorsten Kues, Solutions Manager at ZEISS discusses the launch of ZEISS Celldiscoverer 7, their fully automated microscope and how it will help them to produce data quickly, without compromising on image quality. 

    Nature (26 October 2017)

  • My Green Lab

    Allison Paradise, executive director of My Green Lab, explains how labs could be operating more efficiently be implementing simple cold-storage management best practices and what led to the launch of the first North American Laboratory Freezer Challenge. 

    Nature (05 October 2017)

  • Science Foundation Ireland

    Professor Mark Ferguson Director-General of Science Foundation Ireland and Chief Scientific Adviser to the Government of Ireland, discusses what he believes makes Ireland a destination for researchers and what’s next for research in Ireland

    Nature (05 October 2017)

  • Life Sciences Cluster Basel

    Basel-born Professor Martin Fussenegger discusses why he believes scientists should come and live and work in Basel and why Basel offers many exciting opportunities for innovation and career development 

    Nature (05 October 2017)

  • University of Basel

    Andrea Schenker-Wicki explains how she is putting her expertise managing universities into practice as the president of the University of Basel since 2015. 

    Nature (05 October 2017)

  • Pfizer

    Robert Abraham, Senior Vice President and Group Head of Oncology Research and Development at Pfizer, discusses their postdoc programme and its aim to train and prepare the next generation of innovative scientists. 

    Nature (28 October 2017)

  • Southern Dental

    Peter Keegans, CEO and Ravi Rattan clinical director, discuss the Jacobs Holdings acquisition means for Southern Dental’s dentists, and for the company’s plan to become the largest dental provider in England’s southeast within five years. 

    British Dental Journal (22 September 2017)

  • Evotec

    Mario Polywka, Chief Operating Officer at EvotecAG, explains their industrialized approach to drug discovery and how it aims to make processes more efficient and cost-effective.

    Nature (07 September 2017)

  • Ludwig-Maximilians-Universität (LMU)

    Bernd Huber, LMU’s president, discusses the university's plans and how they set out to recruit foreign researchers, at all career levels, by introducing a number of programmes designed to attract them to Munich. 

    Nature (07 September 2017)

  • Merck

    Dr. Natasha Barteneva, director of Boston Children’s Hospital’s Flow & Imaging Cytometry Resource, lecturer at Harvard Medical School and adjunct professor at Nazarbayev University, describes why the Amnis ImageStream system from MilliporeSigma is so integral to her research.

    Nature (07 September 2017)

  • Kanazawa Institute of Technology (KIT)

    Satoshi Osawa, president of KIT, discusses why KIT's graduates are highly sought-after, and explains that approaches that they use to generate innovation. 

    Nature (17 August 2017)

  • Ambry Genetics

    Dr Aaron Elliott, CEO of Ambry Genetics, discusses the popularity of genetic testing, and thinks genetic counsellors, clinicians, and the public, need to know how they can get the most reliable results.

    Nature (10 August 2017)

  • Science Foundation Ireland

    Professor Mark Ferguson, Director-General of Science Foundation Ireland and Chief Scientific Adviser to the Irish government, discusses their development strategy and plans for the future. 

    Nature (10 August 2017)

  • Gilson

    Josh Pletzke, a chemist at Luminex discusses the GX-271 Oligo Purification System, a liquid handling platform from Gilson and how it has changed oligonucleotide synthesis. 

    Nature (13 July 2017)

  • Hamamatsu

    Keith Bennett, a consultant for Hamamatsu Photonics of Japan, discusses the Hamamatsu technology that allows scientists to generate accurate data with minimal artifacts.

    Nature Methods (01 July 2017)

  • Olav Thon Foundation

    Ole Petter Ottersen, professor of medicine at the University of Oslo, and Liselotte Hoejgaard, professor of medicine and technology at the University of Copenhagen, chair and member of the Olav Thon Foundation’s science advisory board, discuss the Olav Thon Foundation's award and how the nomination process works. 

    Nature (29 June 2017)

  • Abcam

    James Murray, immunoassay product development scientist at Abcam discusses Abcam’s vision when they acquired MitoSciences and the speed at which they can bring high quality, novel kits to the market as a result. 

    Nature (22 June 2017)

  • Gilson

    Klemen Zupančič, Chief executive officer of sciNote, discusses what makes his platform unique, and why sciNote is teaming up with Gilson, a leading instruments company, to make research more robust, verifiable and reproducible. 

    Nature (22 June 2017)

  • Luminex

    Peter Schulz-Knappe, Chief scientific officer at Protagen AG, discusses what attracted him to Luminex and the differences that using FLEXMAP 3D has made to creating assays to support the development of drugs and companion diagnostics at Protagen. 

    Nature (01 June 2017)

  • Merck

    Shawn Shafer PhD, director of advanced genomics at Merck discusses the new CRISPR technology and how Merck aims to further genome science. 

    Nature (01 June 2017)

  • Dentsply Sirona

    Teresa Dolan, Vice President & Chief Clinical Officer at Dentsply Sirona, discusses why dental education is so important and what Dentsply Sirona offers to the field of dental science.

    British Dental Journal (26 May 2017)

  • Ambry Genetics

    Aaron Elliott, CEO of Ambry Genetics, discusses the barriers that they are facing to providing innovative change in healthcare. Here, Aaron outlines how he believes all parties can move forward together to advance treatments and ultimately find cures.

    Nature (25 May 2017)

  • Chinese Academy of Agricultural Sciences

    Tang Huajun, the president of the Chinese Academy of Agricultural Sciences and an expert in geoinformatics outlines their key strengths and plans for international collaboration. 

    Nature (25 May 2017)

  • Hamad Bin Khalifa University Press

    Dr. Alwaleed Alkhaja, senior editor at Hamad Bin Khalifa University Press, discusses its worldclass publishing house and QScience.com, an online, open access, academic publishing platform, to support the academic research output of researchers in Qatar and the Middle East.

    Nature (25 May 2017)

  • Horizon Discovery

    Nicola McCarthy, head of therapeutics research and development at Horizon Discovery explains how Horizon Discovery's scientists are using gene-editing technologies to fight cancer. 

    Nature (25 May 2017)

  • University of Chinese Academy of Sciences

    Ding Zhongli, a geoscience expert with a long-term career at the Chinese Academy of Sciences (CAS) and who leads the University of Chinese Academy of Sciences, outlines his plans to leverage the abundant research resources of CAS to develop a world-class research university. 

    Nature (25 May 2017)

  • Harbin Institute of Technology (HIT)

    Zhen Liang, PhD, assistant president, Harbin Institute of Technology (HIT) and executive vice director of the preparation office for Harbin Institute of Technology, Shenzhen (HITSZ) discusses the creation of HITSZ and outlines their plans for the future. 

    Nature (18 May 2017)

  • State Government of Victoria, Australia

    For six consecutive years, Melbourne has been rated the world’s most liveable city. Here, Dr Amanda Caples, Lead Scientist at the State Government of Victoria, discusses the city's research landscape. 

    Nature (18 May 2017)

  • University of California, Davis

    Dushyant Pathak, Associate Vice Chancellor for Technology Management & Corporate Relations, and Executive Director of Venture Catalyst at the University of California, Davis discusses how the university is driving innovation and technology commercialization. 

    Nature (18 May 2017)

  • BMG LABTECH

    Thomas Räbiger, CEO of BMG LABTECH, discusses the benefits of centralizing research and manufacturing at its headquarters in Germany, and how their customers guide the company’s research priorities.

    Nature (04 May 2017)

  • AstraZeneca

    Nick Brandon, Chief Scientist, Neuroscience, IMED at AstraZeneca, discusses why the IMED Biotech unit is now recruiting its largest single postdoc intake ever.

    Nature (06 April 2017)

  • The Ohio State University

    Caroline Whitacre, Senior Vice President for Research at The Ohio State University discusses the leadership role that the univerisity is taking to solve some of the global challenges of the 21st century. Caroline talks about the initiative, its accomplishments, and the hiring effort behind it.

    Nature (06 April 2017)

  • St. Baldrick's Foundation

    Dr. Jeffrey Lipton, chair of the St. Baldrick’s Scientific Advisory Committee, explains how more research funding could help children with cancer reclaim their childhood from the disease.

    Nature (30 March 2017)

  • STARMUS

    Dr. Garik Israelian, founder of STARMUS and researcher at the Canary Islands Institute of Astrophysics, discusses this year’s festival in Norway, how the festival started, and why is it a major opportunity for science communication. 

    Nature (23 March 2017)

  • Ipsen

    David Meek, Chief Operating Officer at Ipsen, discusses what attracted him to the global biotech company, his plans for geographic expansion and Ipsen's deal strategy. 

    Nature (16 March 2017)

  • Ambry Genetics

    Dr. Aaron Elliott, CEO of Ambry Genetics, discusses AmbryShare, a compilation of Exome sequencing data from more than 11,000 hereditary breast and ovarian cancer patients and why they’re opening their dataset to anyone with an interest in studying it.

    Nature (09 March 2017)

  • Abcam

    Michael Weiner, Vice President of Molecular Sciences at Abcam, discusses the approach Abcam are using to produce recombinant antibodies and how the company’s technology portfolio can raise reproducibility standards for the entire field.

    Nature (02 March 2017)

  • Argos Therapeutics

    Dr. Charles Nicolette, Chief Scientific Officer and Vice President of Research and Development, discusses how Argos Therapeutics is developing individualised, precision cell therapies that are designed to train the body’s immune system, so that patients can fight their own diseases.

    Nature (16 February 2017)

  • Space Bio Laboratories - AS ONE

    Dr. Louis Yuge, Professor at Graduate School of Biomedical & Health Sciences, Hiroshima University, Japan, talks about the development of Gravite®, a device that enables researchers to conduct unprecedented experiments in microgravity and hypergravity conditions.

    Nature (16 February 2017)

  • The Coriell Institute

    Dr. Michael Christman, President and CEO, discussed how Coriell is leveraging its expertise and infrastructure to provide an essential service offering: cell line authentication.

    Nature (16 February 2017)

  • Zhejiang University

    Wu Zhaohui, ZJU president, talks about his plan to accelerate the university’s development into a world-class, comprehensive, innovative research centre.

    Nature (19 January 2017)

2016

  • Almirall

    Dr. Núria Godessart, Head of Skin Biology and Pharmacology at R&D in Almirall, discusses the company's changing focus on dermatology and approach to external collaborations, and what these changes mean for the company, its researchers, and its partners.  

    Nature (24 November 2016)

  • SOLTI

    Dr. Aleix Prat, head of medical oncology at the Hospital Clinic in Barcelona and the scientific committee coordinator for SOLTI, discusses why international collaborations are needed to make progress in the treatment of breast cancer and SOLTI's role in coordinating multi-institutional breast cancer trials.

    Nature (24 November 2016)

  • Centro Médico Teknon

    Dr Josep Rodiera, a MD and PhD, anesthesiologist, with a master’s degree in bioengineering, heads the anesthesiology department at Centro Médico Teknon, a leading private hospital in Barcelona, Spain, and part of the Quirónsalud medical group Fresenius-Helios. Here he discusses the department's goal of achieving personalized, safer care, and transforming the practice of anesthesiology.

    Nature (24 November 2016)

  • Bernal Institute, University of Limerick

    Edmond Magner, Dean of the Faculty of Science & Engineering at the University of Limerick, discusses how the Bernal Institute aims to achieve its goal: building a global reputation in applied sciences and engineering.

    Nature (24 November 2016)

  • Lilly

    Brandy Matthews, MD, Senior Medical Advisor, Alzheimer’s Disease Team at Lilly, explains why the company remains so dedicated to finding treatments that halt the progression of Alzheimer’s and reduce its burden on patients, caregivers and society.  

    Scientific American (01 December 2016)

  • Radius Health Inc.

    Dr. Lorraine Fitzpatrick, Chief Medical Officer, Radius Health Inc., explains the unique viewpoint she brings to developing medicines for women’s health.

    Nature (17 November 2016)

  • The National Collaborative Innovation Centre

    Dr. Yingjin Yuan, Vice President, Tianjin University, discusses his team’s research and his plan for the research platform Synbio to attract international synthetic biologists

    Nature (17 November 2016)

  • Houston Methodist Hospital

    Jenny Chang, Director of the Houston Methodist Cancer Center, discusses the particular challenges of treating the Houston population, and the future of research at the Houston Methodist Cancer Center.

    Nature (10 November 2016)

  • Nanjing Tech University

    Wei Huang, president of NanjingTech and member of the Chinese Academy of Sciences, shares his plan to build a world-class university by boosting Nanjing Tech University's research and expanding its scope. 

    Nature (10 November 2016)

  • Gunma University

    At Japan’s Gunma University, a one-of-a-kind graduate program provides opportunities for students to learn about heavy ion cancer treatments amid a supportive community of medical scientists. Here, Takashi Nakano talks about the advantages of heavy ion therapeutics and welcomes enquiries from prospective applicants interested in playing an active role on the global stage.

    Nature (10 November 2016)

  • Olam

    In 2015, Olam awarded the inaugural Prize for Innovation in Food Security to Professor Norman Uphoff and the SRI International Network and Resources Center (SRI-Rice) at Cornell University. Here, Professor Uphoff, former director of the Cornell International Institute for Food, Agriculture, and Development, discusses SRI-Rice, which was founded in 2010 to support further development and dissemination of the System of Rice Intensification (SRI) synthesized in Madagascar over 30 years ago

    Nature (10 November 2016)

  • The Lieber Institute for Brain Development

    Dr. Daniel Weinberger, Director and Chief Executive Officer of the Johns Hopkinsaffiliated non-profit, explains how Connie Lieber’s vision continues to shape the institute’s unique approach to psychiatric research. The institute is now accepting nominations for the Constance Lieber Prize for Innovation in Developmental Neuroscience, a new $100,000 prize that will be awarded in June of 2017.

    Nature (10 November 2016)

  • Roche

    Sanjay Keswani, senior vice president and global head of Neuroscience, Ophthalmology and Rare Diseases, Roche Pharma Researc, discusses the future of R&D efforts in psychiatry, with the aim of reducing cognitive impairment and negative symptoms associated with schizophrenia, and explains how the seemingly disparate parts of neuroscience, ophthalmology and rare diseases fit together.

    Nature (03 November 2016)

  • RMIT

    Calum Drummond, RMIT’s Deputy Vice-Chancellor of Research and Innovation and Vice President, discusses Enabling Capability Platforms (ECPs), a refined model for universities to innovate, help to unlock value, and, ultimately, become more engaged and relevant to the world beyond academia.

    Nature Index (27 October 2016)

  • Janssen Pharmaceutical Companies of Johnson & Johnson

    Julian Symons, vice president, Disease Area R&D leader, discusses the work his team is doing to advance toward their objective: free every person from the burden of the infection of respiratory syncytial virus (RSV).

    Nature (20 October 2016)

  • Allentown

    Brian Bilecki, Director of Vivarium Design Services at Allentown Inc., speaks about the advantages of exhaust air dust (EAD) protocols for colony health monitoring and the benefits of the Sentinel EAD system

    Lab Animal (20 October 2016)

  • Merck

    Spencer Dreher, principal scientist, discusses how high throughput methods and tools such as the KitAlysis™ Screening Platform can shape the future of drug discovery.

    Nature Chemistry (20 October 2016)

  • Canon BioMedical

    Akiko Tanaka discusses Canon BioMedical's focuses on supporting biomedical and life science research, medical analysis, and healthcare through innovative technologies and solutions.

    Nature (13 October 2016)

  • Bettencourt Schueller Foundation

    The Liliane Bettencourt Prize for Life Sciences, awarded annually by the Bettencourt Schueller Foundation, aims to honour the work of a European researcher aged 45 years and younger who is involved in promising or innovative research.

    Nature (13 October 2016)

  • Charles River

    Emily Hickey speaks about the remarkable success of contract partnerships over the past 15 years and how Charles River is reimagining the role of the CRO across the development lifecycle.

    Nature Biotechnology (13 October 2016)

  • Carl Zeiss Microscopy GmbH

    Annette Bergter discuss the Airyscan detector, a new detector that can be used with standard confocal laser scanning microscopes to increase sensitivity, resolution and speed.

    Nature (29 September 2016)

  • Eisai

    Dr Nadeem Sarwar, president of the Eisai AiM Institute, talks about how the institute is bringing about a new paradigm in human biology driven drug discovery

    Nature (22 September 2016)

  • MilliporeSigma

    Molecular biologist Dennis Ko from the Duke University School of Medicine speaks about how the Guava easyCyte system has come to play a central role in his research.

    Nature (22 September 2016)

  • European Molecular Biology Laboratory

    Alba Diz-Muñoz discusses her motivations for joining EMBL, what life is like at the laboratory, and how the organization supports cutting-edge research

    Nature (22 September 2016)

  • Cell Signaling Technology

    Chief Scientific Officer Roberto Polakiewicz discusses how Cell Signaling Technology rigorously tests all of its products in-house and then works with life scientists around the world to help make their experiments more consistent and reliable.

    Nature (22 September 2016)

  • Transnetyx

    Karen Jackson from the Vanderbilt University Medical Center talks about how the TAGCenter has changed the way researchers and lab animal facilities look at genotyping

    Lab Animal (22 September 2016)

  • H3 Biomedicine

    Vice President of Drug Discovery Biology Peter Smith speaks about some of the most exciting developments in cancer genomics-based therapies and the unique power of H3 Biomedicine’s drug discovery platform.

    Nature (15 September 2016)

  • Janssen Pharmaceutical Companies of Johnson & Johnson

    Lawrence Blatt, who co-leads the Infectious Diseases & Vaccines Therapeutic Area at Janssen, talks about how the company is working to discover and develop transformational therapies to counter these threats

    Nature (01 September 2016)

  • Janssen Pharmaceutical Companies of Johnson & Johnson

    Johan Van Hoof, M.D., Global Therapeutic Head, Infectious Diseases and Vaccines, discusses the importance of vaccines and the technologies his company has deployed to address some of the most challenging infectious diseases.

    Nature (28 July 2016)

  • Softbank

    Shunji Mitsuyoshi, the man who designed the “emotional engine” driving Pepper’s “heart”, explains what makes Pepper unique and what led to his collaboration with SoftBank.

    Nature (14 July 2016)

  • MilliporeSigma

    Dr. Daniel Barreda, a researcher in immunology and animal health at the University of Alberta, Canada, talks about how the ImageStream has accelerated his laboratory’s research.

    Nature (23 June 2016)

  • H3 Biomedicine

    H3 Biomedicine’s Chief Executive Markus Warmuth talks about H3’s success and the future of oncology drug discovery.

    Nature (23 June 2016)

  • Charles River

    Kenneth Henderson explains how sentinel-free cage-monitoring works and how it can help researchers and their labs function more efficiently.

    Lab Animal (23 June 2016)

  • Abcam

    Weimin Zhu discusses the RabMAb antibody platform.

    Nature (16 June 2016)

  • Takeda-CiRA Joint Program

    Shinya Yamanaka, CiRA director and Nobel laureate, talks about the significance of the T-CiRA program and the prospects for its research.

    Nature (26 May 2016)

  • Merck

    Novartis Pharma’s Principal Fellow and Leading Scientist Fabrice Gallou talks about how his chemical development team has benefited from adopting TPGS-750-M.

    Nature Chemistry (24 May 2016)

  • Quadram Institute

    Ian Charles talks about the Quadram Institute and the rapidly emerging science of the human microbiome.

    Nature (12 May 2016)

  • Manchester Science Partnerships

    Chris Doherty explains his vision to secure Alderley Park’s future as a hub for life sciences research.

    Nature (05 May 2016)

  • Radboud university medical center

    Teun Bousema explains how the Hypatia Tenure Track Grant has helped him develop as a scientist and group leader, and reveals how his focus on malaria began by chance in a book shop in Ghana.

    Nature (05 May 2016)

  • Quintiles

    Laurie Witherwax outlines the patient-centric approach that Quintiles deploys to help pharmaceutical and biotechnology companies get new therapies to patients.

    Nature (05 May 2016)

  • Baylor College of Medicine

    Adam Kuspa discuss how Baylor College of Medicine are shifting the way it funds its research and education programmes towards a more sustainable model in which industry plays a bigger role.

    Nature (05 May 2016)

  • TRIANNI

    TRIANNI chief executive Matthias Wabl talks about the TRIANNI mouse platform future of drug discovery.

    Nature (05 May 2016)

  • UC San Diego

    Paul Roben talks about innovation and commercialization for the University of California, San Diego.

    Nature (05 May 2016)

  • Sinobioway

    Aihua Pan discusses his ‘bioeconomy’ system and its application in developing the Sinobioway Group into the world’s origin of bioeconomy.

    Nature (21 April 2016)

  • AstraZeneca

    Daniel Graham explains how algorithms are exciting when they’re saving lives, and why he thinks computer programmers shouldn’t always work from home.

    Nature (07 April 2016)

  • The Jackson Laboratory

    The Jackson Laboratory President Edison Liu talks about a new mouse line and the future of cancer research.

    Nature (31 March 2016)

  • Xi’an Jiaotong University

    Shuguo Wang, president of Xi’an Jiaotong University, reviews its history and discusses its plans to develop into a world-class facility through research innovation and international collaboration.

    Nature (31 March 2016)

  • EMD Millipore

    Kathleen E. McGrath of the University of Rochester Medical School talks about how EMD Millipore’s Amnis brand ImageStream has given her insights into the haematopoiesis of platelets, red blood cells and lymphocytes

    Nature (24 March 2016)

  • Merck Millipore

    Jeffrey A. Borgia reveals how the latest Merck Millipore MILLIPLEX has changed his research dramatically.

    Nature (10 March 2016)

  • Frontiers

    Michel Goldman, field chief editor of Frontiers in Medicine, explains why scientists seeking to improve patients’ lives must think beyond the science and outlines the goals of the Institute for Interdisciplinary Innovation in health care.

    Nature (01 March 2016)

  • University of Tokyo

    ICCPT Project Leader Junji Yumoto discusses the prospects of Coherent photon technology and the role of the ICCPT in its development.

    Nature Photonics (01 March 2016)

  • Phase Holographic Imaging

    Peter Egelberg talks about a new microscopic technique that is helping to change the face of cell biology and drug discovery.

    Nature (04 February 2016)

  • BioHorizons UK

    Ken O’Brien, general manager of BioHorizons UK, talks about the company's recent growth, and why he believes good customer service is the key to success.

    British Dental Journal (22 January 2016)

2015

  • Bettencourt Schueller Foundation

    Thomas Lecuit, research director of the CNRS at the Developmental Biology Institute of Marseille discusses his research, the Bettencourt Schueller prize, and his special interest in butterflies.

    Nature (24 December 2015)

  • Euroscience Open Forum 2016

    Nancy Rothwell, president and vice-chancellor of the University of Manchester, talks about Manchester, and her hopes for the upcoming EuroScience Open Forum event there.

    Nature (24 December 2015)

  • Pfizer

    Richard Connell, vice-president and worldwide head of external research solutions, Pfizer Global Research and Development, speaks about Pfizer’s new partnership with Sigma-Aldrich, and what it means for the research community.

    Nature (24 December 2015)

  • Taconic Biosciences

    Michael Seiler, associate director of product management, immune system models and GEMS-design at Taconic Biosciences, speaks about the company’s new mouse model for oncological and immunological research.

    Nature (17 December 2015)

  • KAIMRC

    Fadia AlBuhairan, Leader of the Adolescent Health Research Program at King Abdullah International Medical Research Center, discusses her research into the health needs of adolescents in Saudi Arabia.

    Nature (17 December 2015)

  • Heilongjiang University of Chinese Medicine

    Xijun Wang, general director of the National TCM Key Lab of Serum Pharmacochemistry at Heilongjiang University of Chinese Medicine, talkse about the links he is building between traditional and contemporary medicine in China.

    Nature (17 December 2015)

  • Frontiers

    Kamila Markram, co-founder and chief executive of Frontiers, talks about Loop — a new social-networking site designed exclusively for researchers.

    Nature (22 October 2015)

  • Olympus

    Brendan Brinkman

    Nature Methods (01 October 2015)

  • Taconic

    Amar Thyagarajan, senior product manager for the neuroscience portfolio at Taconic, discusses the importance of developing mouse models, and how he works closely with his customers to solve scientific challenges.

    Nature (10 September 2015)

  • EMBL

    Judith Zaugg

    NatureJobs (09 September 2015)

  • Siemens

    Trevor Hawkins, Michael Pugia

    Nature (23 July 2015)

  • Decision Lens

    Suple Shea

    Nature Reviews Drug Discovery (01 July 2015)

  • Ipsen

    Claude P. Bertrand, executive vice-president of R&D, and chief scientific officer at Ipsen, discusses the company’s R&D strategy and its collaborative approach to innovation.

    Nature (11 June 2015)

  • KAIMRC

    Ahmed Alaskar, Mohamed Boudjelal

    NatureJobs (03 June 2015)

  • Roche

    Anirvan Ghosh

    NatureJobs (13 May 2015)

2014

sign up to Nature briefing

What matters in science — and why — free in your inbox every weekday.

Sign up

Listen

new-pod-red

Nature Podcast

Our award-winning show features highlights from the week's edition of Nature, interviews with the people behind the science, and in-depth commentary and analysis from journalists around the world.